For instance, small molecule ALK2 inhibitors, such as dorsomorphin, LDN-193189 and LDN-212854 [50], reduced the ALK2 activity and downstream effectors, and effectively against HO in mouse model of FOP [11,42]. Here, ACVR1 is linked to fibrodysplasia ossificans progressiva.